Analyst firms · Capital One · OTLK
Capital One OTLK price target and rating history
Outlook Therapeutics Inc. (OTLK) · Health Care
Capital One rates Outlook Therapeutics Inc. (OTLK) Overweight with a $5 price target, as of its latest action on Dec 27, 2023. It has published 3 rating actions on OTLK since July 2023, including 1 upgrade and 1 downgrade.
- Current rating
- Overweight
- Price target
- $5
- Median target, all firms
- Too few
- Actions on OTLK
- 3
Capital One price target on OTLK
Every Capital One rating on OTLK
- Dec 27, 2023
- Aug 30, 2023
- Jul 13, 2023
Questions about Capital One and OTLK
- What is Capital One's price target for OTLK?
- Capital One's latest stated price target for Outlook Therapeutics Inc. (OTLK) is $5, from its action on Dec 27, 2023.
- What is Capital One's rating on OTLK?
- Capital One rates OTLK Overweight, a bullish rating, as of Dec 27, 2023.
- When did Capital One last change its view on OTLK?
- On Dec 27, 2023, Capital One upgrades to Overweight from Equal Weight, price target $5.
More OTLK rating histories
All Capital One ratingsOTLK news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.